Lacosamide 100mg Tablet PCD Franchise in Mumbai

Antiepileptic Medicine Supplier in Delhi NCR

Epilepsy & Seizure Control Tablet Distributor in Chennai

CNS Pharma Franchise in Kolkata

Lacosamide 100mg Stockist in Pune
Seizure Management Drug Export & Manufacturing in Hyderabad

Home/Products /lacosamide-100-mg-tablet

Lacomasid 100 Tablet

Composition : Lacosamide (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹189/-

Lacomasid 100 Tablet contains Lacosamide 100mg, a novel antiepileptic agent used for managing partial-onset seizures and epilepsy in adults and children. It works by stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing, effectively reducing seizure frequency and severity.

Belonging to the CNS and neurology segment, Lacosamide is increasingly prescribed by neurologists for both monotherapy and adjunct therapy in seizure management. Its well-tolerated profile and clinical efficacy make it a preferred choice for long-term epilepsy treatment.

The 100mg strength is suitable for initiating therapy and flexible dose titration, allowing precise management of seizure control. Its proven efficacy ensures a steady demand in hospitals, neurology clinics, and retail pharmacies.

For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Lacobent 100 Tablet presents a profitable B2B opportunity in the antiepileptic segment, with consistent market demand and high patient adherence across India.

Read More

About the Product

Lacomasid 100 Tablet contains Lacosamide 100mg, a novel antiepileptic agent used for managing partial-onset seizures and epilepsy in adults and children. It works by stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing, effectively reducing seizure frequency and severity.

Belonging to the CNS and neurology segment, Lacosamide is increasingly prescribed by neurologists for both monotherapy and adjunct therapy in seizure management. Its well-tolerated profile and clinical efficacy make it a preferred choice for long-term epilepsy treatment.

The 100mg strength is suitable for initiating therapy and flexible dose titration, allowing precise management of seizure control. Its proven efficacy ensures a steady demand in hospitals, neurology clinics, and retail pharmacies.

For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Lacobent 100 Tablet presents a profitable B2B opportunity in the antiepileptic segment, with consistent market demand and high patient adherence across India.

Common side effects include dizziness, headache, nausea, fatigue, and blurred vision. Rare but serious effects may include cardiac arrhythmias, allergic reactions, or severe dizziness. Seek medical attention if you experience chest pain, fainting, or severe rash.

Used in the treatment of partial-onset seizures in adults and children. It helps reduce the frequency and severity of seizures, improving daily functioning and quality of life.

Take Lacomasid 100 Tablet exactly as prescribed. Do not stop suddenly, as this may trigger seizures. Inform your doctor if you have heart problems, liver or kidney disease, or are taking other antiepileptic medications.

Store below 25°C in a cool, dry place away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation